Skip to Main Content
Contact Us
Category: Early phase
Graphic with Highlights from AusBiotech 2024 Highlights from AusBiotech 2024 Australia Continues to Be Attractive Region for Oncology Trials AusBiotech, in Melbourne, Australia, hosted its Read Now Person at a computer with a bar chart being designed with a stylus. Impacts of Project Optimus on Oncology Trial Costs Exploring creative financial solutions for biotechs Navigating the evolving landscape of early-phase drug development has Read Now woman holds pills and capsules in her hands Ensure Your Oncology Program Is Project Optimus Ready What is Project Optimus? Project Optimus, an initiative from the U.S. Food and Drug Administration Read Now Multicolored pills on white background. FDA Finalizes Project Optimus Guidance for Dosing and Expectations for First-in-Human Oncology Trials The past 18 months have been Read Now Medical professional on the phone and at her computer. Traditional Site Networks Are Broken Building Real Site Relationships to Facilitate the Success of Early Phase Oncology Trials Oncology clinical Read Now Two young business people discussing a project. Rapid First Person In Milestone Less than 2 months for an oncology drug and device development company A drug and Read Now Optimizing Outcomes with Pharmacokinetics (PK) Advancing Oncology Therapeutics Pharmacokinetic endpoints have always been important, but recent U.S. Food and Drug Read Now Catalyst Oncology FIH Rescue Study A clinical-stage biotech company with a critical startup milestone Catalyst Oncology transitioned full-service work from Read Now Male patient speaking with medical professional taking notes Early Phase Oncology Site Network: Benefits of a Personal Touch Network models for large contract research organizations (CROs) tend to focus on high volume and Read Now Close up of colorful pills Catalyst is Project Optimus ready, are you? What is Project Optimus? Project Optimus, an initiative from the FDA, seeks to optimize dosing. Read Now